PFIZER and BIONTECH
PFIZER and BIONTECH announced their mRNA-based vaccine candidate against COVID-19 was >90% effective in first interim efficacy analysis (study enrolled 43,538 participants); submission for Emergency Use Authorization (EUA) is expected in third week of November and companies are projecting global...
Subscription Required
PFIZER and BIONTECH is part of our SpeedNews subscription.
Subscribe now to read this alert, plus receive full coverage of key developments in commercial and business aviation.
Already a subscriber to SpeedNews or a content package that includes SpeedNews? Login
Did you know? Aviation Week has won top honors multiple times in the Jesse H. Neal National Business Journalism Awards, the business-to-business media equivalent of the Pulitzer Prizes.